Case Report: Two Case Reports of Pulmonary Hypertension after mRNA COVID-19 Vaccination

Background: We herein report two cases of sudden onset symptomatic pulmonary hypertension after coronavirus disease 2019 (COVID-19) vaccination. Case Summary: Pulmonary hypertension in previously healthy adult males occurred within three weeks of receiving the second dose of the Pfizer (BNT162b2) mR...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Robert D., Shults, Nataliia V., Suzuki, Yuichiro J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528902/
https://www.ncbi.nlm.nih.gov/pubmed/37754310
http://dx.doi.org/10.3390/diseases11030114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528902/
https://www.ncbi.nlm.nih.gov/pubmed/37754310
http://dx.doi.org/10.3390/diseases11030114

Ejemplares similares